Stay updated on Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial page.

Latest updates to the Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, signaling a version bump for the page. This appears to be a minor, metadata-level update rather than a substantive change to study details.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page’s location text for the Chile site has been updated to use a shorter “Valparaiso” label instead of “Región de Valparaíso.” The displayed site revision/version string was also bumped from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check37 days agoChange DetectedUpdated the collaborator name from Ono Pharmaceutical Co. Ltd to Ono Pharmaceutical Co., Ltd and revised the page version from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded a citation: Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma (N Engl J Med, 2021). Deleted the Erratum entry for that publication.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial page.